Ritedose Launches New Single-Dose Syringe Product: Labetalol Hydrochloride Injection 20 mg/4 mL (5mg/mL) – The Ritedose Corporation

COLUMBIA, S.C. (April 30, 2021) – Ritedose, a 503B outsourcing facility located in South Carolina, just launched a new unit dose syringe product, Labetalol Hydrochloride Injection 20 mg/4 mL (5mg/mL). It is part of a 12-product, six-month rollout from Ritedose for hospital pharmacies across the coun

Cardinal 8881570300 - McKesson Medical-Surgical

Pfizer 00409178269 - McKesson Medical-Surgical

Pfizer Hospital US

Almaject Inc 47781058629 - McKesson Medical-Surgical

Fresenius USA 63323018620 - McKesson Medical-Surgical

Hospira 00409121501 - McKesson Medical-Surgical

Pfizer 00409488820 - McKesson Medical-Surgical

News – The Ritedose Corporation

Fresenius USA 63323048257 - McKesson Medical-Surgical

Akorn 17478017324 - McKesson Medical-Surgical